Tim Schlidt is co-founder and partner at Palo Santo, a psychedelic-focused VC fund with $45mm raised to-date and an active portfolio of 25 companies in the space. Tim brings a rich background in private equity investing and M&A advisory in the life sciences and healthcare services sectors which lends itself well as medicalized psychedelics continue to advance. Tim co-founded Palo Santo out of a long-running interest in advancing novel therapies for the treatment of mental health disorders, and holds a deep passion for advancing psychedelic medicines in a safe, efficacious, and accessible manner.